Drug intelligence / Profile preview

so-cheong-ryong-tang

Development stage
Phase 3
Lead developer
Tsumura
Modality
Small Molecules
Administration
Oral
01

Overview

So-Cheong-Ryong-Tang (SCRT) is a traditional East Asian herbal medicine composed of eight medicinal herbs: *Ephedra sinica*, *Glycyrrhiza uralensis*, *Schisandra chinensis*, *Asarum sieboldii*, *Pinellia ternata*, *Paeonia lactiflora*, *Cinnamomum cassia*, and *Zingiber officinale*. It is widely used in Korea, China, and Japan for the treatment of allergic and respiratory diseases, including asthma, allergic rhinitis, and atopic dermatitis. SCRT exerts its therapeutic effects through immunomodulatory and anti-inflammatory mechanisms, primarily by suppressing Th2-mediated immune responses. It inhibits the production of Th2 cytokines such as IL-4, IL-5, and IL-13, reduces serum IgE levels, and stabilizes mast cells to prevent histamine release. Additionally, it modulates the NF-κB signaling pathway and reduces the expression of pro-inflammatory mediators like TNF-α and COX-2.

Brand names
Sho-seiryu-toXiao-Qing-Long-Tang
Other names
Minor Blue Dragon DecoctionXiaoqinglong-tangSho-seiryu-to
02

Targets

TNFA (Tumor necrosis factor alpha (soluble))IgE (Immunoglobulin E)IL-4 (Interleukin 4)IL-5 (Interleukin 5)NF-κBIL-13 (Interleukin-13)

Beyond the preview

Go deeper on so-cheong-ryong-tang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on so-cheong-ryong-tang.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call